OSPOMYV
"OSPOMYV" is a word mark owned by Samsung Bioepis Co., Ltd., filed at the USPTO on August 27, 2024. It is registered and covers class 5 (Pharmaceuticals).
- Status
- Registered
- Since June 17, 2025
- Filed
- August 27, 2024
- Registered
- June 17, 2025
- Priority date
- August 23, 2024
- Claimed from South Korea
- Application no.
- 98719722
- Registration no.
- 7832505
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns OSPOMYV
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Samsung Bioepis Co., Ltd.
Incheon, South Korea
Representative
Charles T. J. Weigell
Fross Zelnick Lehrman & Zissu, P.C.
What the mark covers
The products and services OSPOMYV is filed for, grouped by Nice class.
Pharmaceutical preparations for the treatment of hematological, autoimmune, inflammatory, respiratory, and transplantation-related diseases and disorders; pharmaceutical preparations for the treatment of generalized myasthenia gravis; dietary supplements; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for the treatment of osteoporosis; human vaccine preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the treatment of musculoskeletal disorders; pharmaceutical preparations, namely, pharmaceutical preparations, biological formulations, biological preparations, antibody formulations and protein formulations for immunoregulation and for treatment of immunologic disorders, autoimmune diseases, inflammatory diseases, arthritis, cancer, tumor, central nervous system disorders and metabolic diseases; pharmaceutical preparations for the treatment of bone fractures; pharmaceutical preparations for the prevention of diseases of the musculoskeletal system; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for tumor treatment; preparations for treatment of cancer; preparations for treatment of tumour diseases; preparations for treatment of multiple myeloma; pharmaceutical preparations for the treatment of skeletal diseases; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for the treatment of solid cancer
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
- Approved for pub - principal register
- Teas/email correspondence entered
- Correspondence received in law office
- Teas response to office action received
- Notification of non-final action e-mailed
8 earlier steps on the official record.
About OSPOMYV
Who owns the trademark "OSPOMYV"?
The USPTO trademark "OSPOMYV" (application 98719722) is owned by Samsung Bioepis Co., Ltd.
What is the status of "OSPOMYV"?
Its status at the USPTO is: registered.
When was "OSPOMYV" registered?
It was registered on June 17, 2025.
Get this data via the API
Everything on this page comes from the Signa API. Pull OSPOMYV and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2954-3774-76f2-8ae6-cc0720978288
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2954-3774-76f2-8ae6-cc0720978288",
"object": "trademark",
"mark_text": "OSPOMYV",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "98719722",
"filing_date": "2024-08-27",
"nice_classes": [
5
],
"owners": [
{
"name": "SAMSUNG BIOEPIS CO., LTD.",
"entity_id": "ent_019eb7c8-63f6-758a-8736-c654508d57c5"
}
]
}